CC
JSPR icon

Centiva Capital’s Jasper Therapeutics JSPR Stock Holding History

Centiva Capital’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,000
Closed -$298K – 1501
2021
Q1 		$298K Buy
+3,000
New +$305K 0.01% 776

Other funds holding JSPR

MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return

Centiva Capital's JSPR Position: Q2 2021 in Review

Centiva Capital sold out of Jasper Therapeutics (JSPR) in Q2 2021, closing a stake of 3,000 shares — an estimated $298K sold.

Centiva Capital first reported a position in JSPR in Q1 2021 and held it in 1 quarter. The position peaked at $298K in Q1 2021. 58 funds tracked by Wall St. Rank hold JSPR as of Q2 2021.

  • Centiva Capital reported no remaining Jasper Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Centiva Capital sold 3,000 Jasper Therapeutics shares in Q2 2021, an estimated $298K.
  • Centiva Capital first reported a position in Jasper Therapeutics in Q1 2021 and held it in 1 quarter.
  • Centiva Capital's Jasper Therapeutics position peaked at $298K in Q1 2021.
  • 58 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2021.

Based on Centiva Capital's 13F filing for Q2 2021, filed 16 Aug 2021.